Cargando…

Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma

Background: Single-cell RNA sequencing is necessary to understand tumor heterogeneity, and the cell type heterogeneity of lung adenocarcinoma (LUAD) has not been fully studied. Method: We first reduced the dimensionality of the GSE149655 single-cell data. Then, we statistically analysed the subpopul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yong, Wang, Yao, Liang, Leilei, Song, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486955/ https://www.ncbi.nlm.nih.gov/pubmed/36147484 http://dx.doi.org/10.3389/fgene.2022.975542

Ejemplares similares

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2022)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Differential Infiltration of Immune Cells Driven by Tumor Heterogeneity Reveals Two Immune Subtypes in Lung Adenocarcinoma
por: Wang, Liqiang, et al.
Publicado: (2022)

The Impact of Heterogeneity on Single-Cell Sequencing
por: Goldman, Samantha L., et al.
Publicado: (2019)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma
por: Li, Zhaoshui, et al.
Publicado: (2022)

A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma
por: Wang, Xitao, et al.
Publicado: (2022)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Single-cell RNA Sequencing Reveals Heterogeneity of Cultured Bovine Satellite Cells
por: Lyu, Pengcheng, et al.
Publicado: (2021)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
por: Ye, Chenyang, et al.
Publicado: (2022)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
por: Yang, Jian, et al.
Publicado: (2022)

Single-Cell RNA Sequencing-Based Computational Analysis to Describe Disease Heterogeneity
por: Zeng, Tao, et al.
Publicado: (2019)

Single-Cell RNA Sequencing Reveals Smooth Muscle Cells Heterogeneity in Experimental Aortic Dissection
por: Xu, Cheng, et al.
Publicado: (2022)

BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma
por: Lin, Yuansheng, et al.
Publicado: (2022)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

Exploration the global single-cell ecological landscape of adenomyosis-related cell clusters by single-cell RNA sequencing
por: Lin, Jiajing, et al.
Publicado: (2022)

Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma
por: Chen, Yifan, et al.
Publicado: (2023)

Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis
por: Liu, Cheng, et al.
Publicado: (2020)

A Nomogram Integrating Ferroptosis- and Immune-Related Biomarkers for Prediction of Overall Survival in Lung Adenocarcinoma
por: Chai, Mengyu, et al.
Publicado: (2021)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
por: Ruan, Guo-Tian, et al.
Publicado: (2022)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration
por: Zhang, Yetao, et al.
Publicado: (2023)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis
por: Huang, Yuancheng, et al.
Publicado: (2022)

Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma
por: Wang, Youyu, et al.
Publicado: (2021)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma
por: Zhang, Dexin, et al.
Publicado: (2023)

Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients
por: Tang, Yu, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations
por: He, Di, et al.
Publicado: (2020)

Genomics and Prognosis Analysis of N(6)-Methyladenosine Regulators in Lung Adenocarcinoma
por: Ma, Yanpin, et al.
Publicado: (2021)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hfnfmssofej4g908b2sl80q1fh